5don MSN
Morgan Stanley backs Tenaya Therapeutics (TNYA) as SMID-cap biotech primed to outperform in 2026
Tenaya Therapeutics Inc. (NASDAQ:TNYA) is one of the overlooked growth stocks to buy. On January 8, Morgan Stanley lowered ...
In this piece, we discuss the 10 Best Small-Cap Biotech Stocks to Buy According to Analysts. Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention. This ...
Nvidia and Palantir lead a relief rally as the Greenland Golden Dome deal reverses tariff fears. See why the Russell 2000 ...
Both Ironwood Pharmaceuticals IRWD and Puma Biotechnology PBYI are small biotechs, concentrating on the successful commercialization of their respective products with the goal of establishing ...
Acadia Pharma’s Catherine Owen Adams has formed a group of small- to mid-cap biotechs to advocate against a ‘peanut butter ...
Speculative investors and patience rarely go hand in hand. Nevertheless, if you’re looking to invest in the small-cap biotech sector, patience is a requirement. Most, if not all, of these companies ...
The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) is one of the stocks under $1 that will explode. On January 8, 2026, TheFly reported ...
State Street SPDR S&P Biotech ETF (XBI) has surged nearly 30% YTD, regaining the attention of Wall Street. The outperformance is due to an equal-weight structure, which makes it a high-beta instrument ...
Small-cap funds on average have lagged their benchmarks by wide margins this year while putting up respectable absolute returns. Strategies that avoid speculative small caps and focus on higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results